School of Engineering
Showing 1-10 of 14 Results
MD Student with Scholarly Concentration in Bioengineering, expected graduation Spring 2018
Ph.D. Student in Bioengineering with Scholarly Concentration in Bioengineering, admitted Summer 2016
Current Research and Scholarly InterestsArtificial intelligence, machine learning, synthetic biology, and genomics
Alison Marsden, PhD
Associate Professor of Pediatrics (Cardiology) and of Bioengineering and, by courtesy, of Mechanical Engineering
Current Research and Scholarly InterestsThe Cardiovascular Biomechanics Computation Lab at Stanford develops novel computational methods for the study of cardiovascular disease progression, surgical methods, and medical devices. We have a particular interest in pediatric cardiology, and use virtual surgery to design novel surgical concepts for children born with heart defects.
Ph.D. Student in Bioengineering, admitted Autumn 2014
BioImmunotherapy has the potential to become the new paradigm of cancer treatment. While anatomic imaging has been the gold standard to monitor treatment efficacy based upon decreases in tumor size, patients treated with immunotherapies often present with a period of apparent tumor growth before prolonged regression. Due to the high cost and delayed response time, there exists a compelling need to accurately predict which patients are most likely to benefit from immune based treatment strategies. Aaron hopes to develop a molecular imaging toolkit including novel software, hardware, and biological wetware to improve monitoring of cancer immunotherapies in the clinic. He is advised on this project by Dr. Sam Gambhir. Aaron brings with him experience in multi-modality molecular imaging of cancer from his time spent under the mentorship of Dr. Efstathios Karathanasis and Dr. Mark Griswold at the Case Center for Imaging Research in Cleveland, Ohio. After graduating from CWRU, Aaron spent a year in Switzerland as a Fulbright Fellow at the Ecole Polytechnique Federale de Lausanne (EPFL) where, with the guidance of Dr. Melody Swartz and Dr. Jeffrey Hubbell, he utilized imaging tools to better understand the mechanisms of therapeutic cancer vaccines.
Lloyd B. Minor, MD
The Carl and Elizabeth Naumann Professorship for the Dean of the School of Medicine, Professor of Otolaryngology—Head & Neck Surgery and, by courtesy, of Neurobiology and Bioengineering
BioLloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine, a position he has held since December 2012.
As dean, Dr. Minor plays an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Children’s Health and Lucile Packard Children’s Hospital Stanford. He also oversees the quality of Stanford Medicine’s physician practices and growing clinical networks.
With Dr. Minor’s leadership, Stanford Medicine has established a strategic vision to lead the biomedical revolution in Precision Health. The next generation of health care, Precision Health is focused on keeping people healthy and providing care that is tailored to individual variations. It’s predictive, proactive, preemptive, personalized, and patient-centered.
An advocate for innovation, Dr. Minor has provided significant support for fundamental science and for clinical and translational research at Stanford. Through bold initiatives in medical education and increased support for PhD students, Dr. Minor is committed to inspiring and training future leaders.
Among other accomplishments Dr. Minor has led the development and implementation of an innovative model for cancer research and patient care delivery at Stanford Medicine and has launched an initiative in biomedical data science to harness the power of big data and create a learning health care system. Committed to diversity, he has increased student financial aid and expanded faculty leadership opportunities.
Before coming to Stanford, Dr. Minor was provost and senior vice president for academic affairs of The Johns Hopkins University. During his time as provost, Dr. Minor launched many university-wide initiatives such as the Gateway Sciences Initiative to support pedagogical innovation, and the Doctor of Philosophy Board to promote excellence in PhD education. He worked with others around the university and health system to coordinate the Individualized Health Initiative, which aimed to use genetic information to transform health care.
Prior to his appointment as provost in 2009, Dr. Minor served as the Andelot Professor and director (chair) of the Department of Otolaryngology–Head and Neck Surgery in the Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital. During his six-year tenure, he expanded annual research funding by more than half and increased clinical activity by more than 30 percent, while strengthening teaching efforts and student training.
With more than 140 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders. Through neurophysiological investigations of eye movements and neuronal pathways, his work has identified adaptive mechanisms responsible for compensation to vestibular injury in a model system for studies of motor learning (the vestibulo-ocular reflex). The synergies between this basic research and clinical studies have led to improved methods for the diagnosis and treatment of balance disorders. In recognition of his work in refining a treatment for Ménière’s disease, Dr. Minor received the Prosper Ménière Society’s gold medal in 2010.
In the medical community, Dr. Minor is perhaps best known for his discovery of superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. In 1998 Dr. Minor and colleagues published a description of the clinical manifestations of the syndrome and related its cause to an opening (dehiscence) in the bone covering the superior canal. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms.
In 2012, Dr. Minor was elected to the National Academy of Medicine, formerly the Institute of Medicine.